Phase II clinical trial on systemic oxaliplatin chemotherapy plus molecular target therapy combined with hepatic arterial infusion (HAI) therapy for colorectal liver metastases
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Interventions: Period of intervension: 8 cycles of chemotherapy, mainly for 6 months. Primary outcome(s): Two-year relative-free survival after liver surgery Overall survival Study Design: Single arm Non-randomized
创建时间：
2015-10-15
